The largest database of trusted experimental protocols

4 protocols using ky02111

1

Xeno-free Cardiomyocyte Differentiation from hPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Xeno-free differentiation of hPSCs toward cardiomyocytes was carried out as we described recently [18 (link)]. Briefly, 5 × 106 cells were seeded as single cells in spinner flasks (Corning Inc., Corning, NY, USA) with 50 mL StemMACS iPS-Brew XF culture medium (Miltenyi Biotech, Auburn, CA, USA). After 5 days of hPSC expansion as aggregates, the medium was replaced with xeno-free differentiation medium (DM) supplemented with 200 ng/mL WNT3A and 30 ng/mL BMP4. Medium was changed after 24 h. Forty-eight hours later, DM with 10 µM KY02111 (R&D Systems, Minneapolis, MN, USA) Wnt inhibitor was added and replaced daily for 6 days. Cells were then cultured in DM until day 13 with daily medium exchange.
+ Open protocol
+ Expand
2

Cardiac Differentiation of Human Pluripotent Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Undifferentiated hPSCs were seeded onto Matrigel-coated dishes at a density of 4 × 104 cells/cm2 and allowed to expand for 48 h (∼80% confluency). At this stage (d1 of differentiation), cultures were treated with medium comprising StemPro34 supplemented with (1:100 dilution) Matrigel and (1 ng/mL) BMP4 (R&D systems) and after 24 h (d2 of differentiation), medium comprising StemPro34 with (10 ng/mL) BMP4 and (8 ng/mL) Activin A (Life Technologies). Medium exchange was performed on d4 of differentiation using RPMI supplemented with 1xB27 (Life Technologies) and small molecule inhibitors, KY02111 (10 μM) and XAV939 (10 μM) (R&D systems). From d8 onward, cells were maintained in RPMI medium supplemented with B27 only, with medium changes every 3 days. Cardiac differentiation efficiency was accessed by using immunocytochemistry with primary mouse anti-human α-actinin antibody (No. A7811, 1:800; Sigma) dilution and secondary goat anti-rabbit Alexa633 (No. A21052, 1:400; Invitrogen), counterstaining with 0.5 μg/mL DAPI (No. D9542, 1:500; Sigma). Immunofluorescence images were captured using Operetta High-Content System (Perkin Elmer) and analyzed using Harmony High-Content Analysis Software.
+ Open protocol
+ Expand
3

Directed Differentiation of hPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
In preparation for differentiation cells were seeded at 4–8 × 105 cells/cm2 and after 6 days of expansion, differentiation was induced (day 0) by washing the cells with PBS (Sigma-Aldrich, St. Louis, MO) and adding xeno-free differentiation medium (XF; Table 1) containing BMP4 and WNT3A (R&D Systems, Minneapolis, MN) at stated concentrations. The next day, this medium was replaced with XF medium without BMP4 and WNT3A. From day 2 to 8, cells were incubated in XF with 10 μM KY02111 (R&D Systems, Minneapolis, MN) replenished daily. From day 9 on cells were cultured in XF, which was replaced daily.
Differentiation in spinner flasks was carried out after 5 days of hPSC expansion as aggregates. Subsequently aggregates were transferred to centrifuge tubes and spun down at 100 × g for 5 min. The medium was aspirated, aggregates were washed with PBS, and XF was added containing 30 ng/ml BMP4 and 200 ng/ml WNT3A (alternatively, 6 μM CHIR99021 was added) before returning the aggregate suspension to the spinner flasks. Differentiation in the spinner flasks proceeded using the same media and timing as in dish cultures.
+ Open protocol
+ Expand
4

Stepwise Cardiomyocyte Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Undifferentiated hPSCs were seeded onto Matrigel™-coated dishes at a density of 1 × 105 cells/cm2, and allowed to expand for 72 h until confluent. At this stage, (day 1 of differentiation) cells were treated with medium A consisting of StemPro-34 (Life Technologies) medium, recombinant human Activin A (Life Technologies) and recombinant human BMP4 (R&D Systems). Media exchange was performed on day 3 with medium B- consisting of RPMI base medium (Life Technologies) supplemented with 1× B-27 (Life Technologies) and a small molecule inhibitor, KY02111 (R&D Systems). From day 5 onward, cells were maintained in RPMI base medium supplemented with B-27 only, and media changes were performed every 2–3 days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!